PARSIFAL
OFFICIAL TITLE: STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB IN COMBINATION WITH FULVESTRANT OR LETROZOLE IN PATIENTS WITH ER+, HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER.
CLINICAL TRIAL DETAILS
A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB IN COMBINATION WITH FULVESTRANT OR LETROZOLE IN PATIENTS WITH HER2 NEGATIVE, ER+ METASTATIC BREAST CANCER.
THIS IS AN INTERNATIONAL, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTICENTER PHASE II CLINICAL TRIAL TO INVESTIGATE AND COMPARE THE SAFETY AND EFFICACY OF PALBOCICLIB COMBINED WITH FULVESTRANT OR LETROZOLE IN WOMEN WITH ER+, HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER.
PARSIFAL AT CLINICALTRIALS.GOV
TUMOR TYPE
PHASE
HR+ HER2neg ABC
II
486
50
Spain, France, Italy, UK, Germany, Russia, Czech Republic
N
SITES
COUNTRY
STATUS
Closing
PRESS RELEASE
BLOG ARTICLES RELATED
SCIENTIFIC IMPACT
SABCS 2022 – DOWNLOAD THE POSTER
SABCS 2020 – DOWNLOAD THE POSTER
SABCS 2020 – DOWNLOAD LIST OF COI'S
ESMO 2016 – DOWNLOAD THE POSTER
PARSIFAL SITES
SPAIN
Hospital Universitari Vall D'Hebron
SPAIN
Instituto Valenciano de Oncología (IVO)
SPAIN
Hospital Universitario Reina Sofía
SPAIN
Institut Català d' Oncologia L'Hospitalet (ICO)
SPAIN
Hospital del Mar
SPAIN
Hospital Universitario Central de Asturias (HUCA)
SPAIN
Hospital Universitario Virgen del Rocío
SPAIN
Institut Català d' Oncologia Girona (ICO)
SPAIN
Hospital Universitari Sant Joan de Reus
SPAIN
Hospital Universitario Juan Ramón Jiménez
SPAIN
Complejo Hospitalario de Navarra
SPAIN
Hospital San Pedro de Alcántara
SPAIN
Hospital Universitario de Basurto
SPAIN
Hospital Clínico Universitario Lozano Blesa
SPAIN
Hospital Universitario Miguel Servet
SPAIN
Complejo Hospitalario Universitario de Santiago (CHUS)
SPAIN
Hospital Universitario La Paz
SPAIN
Hospital Provincial de Castellón
SPAIN
Instituto Oncológico Baselga - Hospital Quiron Salud Barcelona
SPAIN
Hospital Arnau de Vilanova de Valencia
FRANCE
Hôpital Tenon AP-HP
FRANCE
Institut Universitaire du Cancer Toulouse, Toulouse
FRANCE
Institut Curie
FRANCE
Centre Paul Strauss
FRANCE
Hopital Europeen Georges Pompidou
ITALY
Fondazione IRCCS Istituto Nazionale dei Tumori
ITALY
Instituto Europeo di Oncologia
ITALY
AOU policlinico di Modena
ITALY
Ospedale San Gerardo
ITALY
Ospedale Antonio Perrino
ITALY
Istituti Ospitalieri Cremona
ITALY
Ospedale Guglielmo da Saliceto
ITALY
Azienda Ospedaliero-Universitaria Cittá de la Salute e della Scienza
ITALY
Azienda Ospedaliero- Universitaria di Cagliari
UK
Barts Cancer Institute
UK
Royal United Hospitals Bath NHS Foundation Trust
UK
Nottingham University Hospitals NHS Trust
UK
Abertawe Bro Morgannwg University Local Health Board, Singleton Hospital
UK
Queens Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust
UK
Royal Cornwall Hospital NHS Trust
UK
The Christie NHS Foundation Trust
GERMANY
National Center for Tumor Disease (NCT)
GERMANY
Medizinisches Versorgungszentrum des Städtischen Klinikums Dessau (MVZ) - Frauenheilkunde
CZECH REPUBLIC
General University Hospital in Prague
CZECH REPUBLIC
Onkologická klinika Fakultní nemocnice Olomouc
RUSSIA
Regional Clinical Oncology Hospital
RUSSIA
Moscow Clinical Scientific Center of the Moscow Health Department
RUSSIA
Republican Clinical Oncological Dispesary of Tatarstan Ministry of Health
RUSSIA
St. Petersburg Clinical Research and Practical Center of Specialized Types of Medical Care
RUSSIA
Oncologic Dispensary of Pyatigorsk